Happy New Year! In this issue of the Innovation Partners BioBlog, we focus on the five top stories to watch in 2020 plus updates on new breast cancer treatments. Surprise billing, high drug prices, and the debate over Obama Care continue to lead news coverage for the health industry. Read more in this edition of ...

Happy New Year! We wish everyone a happy, healthy, and prosperous New Year. Here’s to a wonderful 2020! In this week’s Innovation Partners BioBlog, we update a few of 2019’s top stories regarding the ACA and proposals to lower the cost of prescription drugs. A new partnership between Massachusetts BCBS and Amazon’s PillPack moves ahead, ...

Happy Holidays from Innovation Partners! We hope everyone has a lovely holiday and a Happy New Year. We’re heading into an election year, and that means that several bills on Capitol Hill may be stalled until after November. Lobbyists continue to meet with lawmakers about Nancy Pelosi’s drug pricing bill, predicting it will squelch innovation ...

This week, cancer treatment and care are in the spotlight in the Innovation Partners BioBlog. Treatment for AML and new drugs to target various cancers are in the news in addition to the price transparency rule and findings related to Medicare charges. Read on for more in this week's Innovation Partners BioBlog. Hospitals sue CMS ...

This week's Innovation Partners BioBlog focuses on moves that drug companies are making both here and abroad. Canada pushed back at President Trump's plans to import drugs from Canada. Novartis plans to open a gene cell therapy manufacturing plant in Stein, Switzerland, to eliminate costly and time-consuming transatlantic flights of its medications from New Jersey ...

The pushback continues against the impending enactment in 2020 of a tax on medical devices, part of the Affordable Care Act legislation that's been delayed for ten years. Humana reports favorable results with its Medicare Advantage plans and provides evidence that it both saves money and improves outcomes. UnitedHealthcare will open MA centers in Walgreens ...

This week’s Innovation Partners BioBlog examines two emerging trends: fewer people enrolling in the Affordable Care Act and more people choosing $0 premiums during Medicare enrollment. President Trump continues to push to mandate low drug prices while the drug makers push back. These and more are the top stories in this week’s Innovation Partners BioBlog. ...

This week, the Innovation Partners BioBlog looks are breaking articles on how technology can help the shift to new healthcare payment models. Voters agree that the soaring cost of drug prices should be curbed, but disagree on how to do so. CMS delayed its ruling to hospitals and healthcare providers to post their prices, stating ...

In this week’s Innovation Partners BioBlog, we look at many of the top stories highlighting the conversation about drug prices. Canada’s acting ambassador nixes the Trump Administration’s suggestion that Canadian drug imports will lower prices. Neulasta has another competitor as a third biosimilar enters the market. And a top regulator of Medicare and Medicaid decries ...

In this week’s Innovation Partners BioBlog, we look at top stories impacting the world of healthcare especially those affected by politics and legislation. Senator Pelosi pushes for passage of her bill to lower drug prices but opponents believe it will stifle innovation and the development of new drugs. The Trump Administration delayed the start of ...